Iodide

Iodide

SCHEMBL6037445

CC(C)(C)c1cccc(OC(=O)C(Cl)Cl)c1C(C)(C)C.I

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
CA2 P00918 1/20 0.36
BCHE P06276 1/20 0.36
PDK1 Q15118 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
NAMPT P43490 1/20 0.35
NLRP3 Q96P20 1/20 0.35
MAPT P10636 1/20 0.34
RBP4 P02753 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL700592 0.84 KDM4E (0.42) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL3902495 0.83 KDM4E (0.41) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL246229 0.82 TDP1 (0.45) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL247427 0.80 TDP1 (0.47) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL700593 0.80 RBP4 (0.44) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL10662158 0.77 TDP1 (0.46) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL2050525 0.76 TDP1 (0.41) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL21596952 0.75 TDP1 (0.43) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL247541 0.74 ATM (0.46) ATMTDP1KDM4EALDH1A1GAA
SCHEMBL10662161 0.74 TDP1 (0.49) ATMTDP1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083697-A Chemical amplification for the synthesis of patterned arrays AFFYMETRIX, INC. (US) 2000-07-04 US claimed
US-20060141511-A1 Chemical amplification for the synthesis of patterned arrays AFFYMETRIX, INC (US) 2006-06-29 US disclosed
US-7053198-B2 Functionated photoacid generator and functionated polymer system for biological microarray synthesis AFFYMETRIX, INC. (US) 2006-05-30 US disclosed
US-20040203056-A1 Chemical amplification for the synthesis of patterned arrays AFFYMETRIX, INC. 2004-10-14 US disclosed
US-6770436-B1 RADIATION-ACTIVATED CATALYSTS (RACS), AUTOCATALYTIC REACTIONS, AND PROTECTIVE GROUPS ARE EMPLOYED TO ACHIEVE A HIGHLY SENSITIVE, HIGH RESOLUTION, RADIATION DIRECTED COMBINATORIAL SYNTHESIS OF PATTERN ARRAYS OF DIVERSE POLYMERS AFFYMETRIX, INC. 2004-08-03 US disclosed
US-20040109935-A1 Functionated photoacid generator and functionated polymer system for biological microarray synthesis AFFYMETRIX, INC. 2004-06-10 US disclosed
US-20040110133-A1 Functionated photoacid generator for biological microarray synthesis AFFYMETRIX, INC. 2004-06-10 US disclosed
EP-0946286-B1 CHEMICAL AMPLIFICATION FOR THE SYNTHESIS OF PATTERNED ARRAYS AFFYMETRIX INC (US) 2003-03-19 EP disclosed
US-6083697-A Chemical amplification for the synthesis of patterned arrays AFFYMETRIX, INC. (US) 2000-07-04 US disclosed
EP-0946286-A1 CHEMICAL AMPLIFICATION FOR THE SYNTHESIS OF PATTERNED ARRAYS Affymetrix, Inc. (a California Corporation) (US) 1999-10-06 EP disclosed
WO-1998020967-A1 CHEMICAL AMPLIFICATION FOR THE SYNTHESIS OF PATTERNED ARRAYS AFFYMETRIX, INC. (US) 1998-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040203056-A1 Chemical amplification for the synthesis of patterned arrays PARG, RAD18, RAC2 ATM 848/4885TDP1 958/4885KDM4E 3884/4885
US-20060141511-A1 Chemical amplification for the synthesis of patterned arrays PARG, RAD18, RAC2 ATM 976/4885TDP1 1096/4885KDM4E 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.